Physician profile
Ying Gu
NPI 1215193487
$3,307.77
in general payments reported to CMS, 2019-2025
19 companies · $555 in 2025
The $555 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $136 · 2021: $79.76 · 2022: $238 · 2023: $385 · 2024: $820 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,760.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,405.07 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $426.46 | 2019-2025 | Mounjaro, Jardiance |
| Gilead Sciences, INC. | $412.13 | 2019-2023 | |
| Novo Nordisk INC | $310.21 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $132.99 | 2019 | |
| Alexion Pharmaceuticals, INC. | $127.49 | 2023-2025 | Ultomiris |
| Amgen INC. | $106.29 | 2024-2025 | Otezla, Repatha, Repatha |
| Hologic Sales and Service, LLC | $89.57 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $84.68 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.58 | 2022-2025 | Jardiance |
| Abbott Laboratories | $31.11 | 2022 | |
| Astellas Pharma US INC | $29.50 | 2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $20.55 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.50 | 2023 | Gattex |
| Pfizer INC. | $17.39 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.00 | 2022 | |
| Glaxosmithkline, LLC. | $16.62 | 2025 | |
| Scynexis, INC. | $15.02 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ying Gu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.